이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Acute Blood Flow Restriction Walking on Immune Cell Phenotype and Function

2026년 11월 3일 업데이트: Jonathan Little, University of British Columbia

Impact of Acute Blood Flow Restriction Walking on Immune Cell Phenotype and Function in Adults withT2D

To conduct a randomized control trial to determine the impact of acute blood flow restriction treadmill walking on immune cell counts, function, and phenotype in adults living with type 2 diabetes.

연구 개요

상세 설명

Participants will be randomized to a regular treadmill walking condition or treadmill walking with blood flow restriction (BFR) condition. In both groups participants will complete 32 minutes of treadmill walking at a speed and grade that elicit 40-50% heart rate reserve. In the BFR group the cuffs will be inflated based on each participants individualized limb occlusion pressure (LOP). The cuffs will remain inflated for the entire session but will deflate for 1 minute every 10 minutes based on safety recommendations. The percentage of LOP will 60%. Blood samples will be obtained pre-exercise (PRE), during the final 2 minutes of the final occlusion cycle (OCC), and 3 minutes into the recovery period post-exercise (POST) to measure outcomes.

연구 유형

중재적

등록 (추정된)

20

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 장소

    • British Columbia
      • Kelowna, British Columbia, 캐나다, V1V 1V7
        • 모병
        • University of British Columbia Okanagan
        • 연락하다:

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

19년 (성인)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Aged 19-64 years
  • Diagnosed with type 2 diabetes with current HbA1c 5.7-9.0%
  • Completing <150 minutes of moderate-vigorous physical activity per week.

Exclusion Criteria:

  • Chronic musculoskeletal condition or recent (within 2 years) cardiovascular event preventing participation in exercise.
  • Unstable type 2 diabetes medication of the last 3 months
  • Absolute contraindications to BFR (i.e., peripheral vascular disease)
  • A self-reported diagnosis of low iron concentrations, anemia, or being treated for these conditions
  • A diagnosis of any red blood cell-altering condition (i.e., sickle cell anemia, poikilocytosis)
  • Currently living with any cardiovascular disease, which would impact the ability to participate in exercise safely
  • Currently prescribed any medication which would impact the ability to use a heart rate monitor to accurately track intensity

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 기초 과학
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Treadmill walking with blood flow restriction

Treadmill walking with blood flow restriction.

Participants will complete 32 minutes of treadmill walking at a speed and grade that elicit 40-50% heart rate reserve. The cuffs will be inflated based on each participants individualized limb occlusion pressure (LOP). The cuffs will remain inflated for the entire session but will deflate for 1 minute every 10 minutes based on safety recommendations. The percentage of LOP will 60%.

활성 비교기: Treadmill Walking

Treadmill walking.

Participants will complete 32 minutes of treadmill walking at a speed and grade that elicit 40-50% heart rate reserve.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Change in white blood cell count before, during, and after exercise.
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The white blood cell count will be measured using a hematology analyzer before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise

2차 결과 측정

결과 측정
측정값 설명
기간
Change in monocyte count before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The monocyte count will be measured using a hematology analyzer before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in neutrophil count before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The neutrophil count will be measured using a hematology analyzer before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in eosinophil count before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The eosinophil count will be measured using a hematology analyzer before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in CD66b+ expression before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The CD66b+ expression will be measured using flow cytometry before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in CD11b+ expression before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The CD11b+ expression will be measured using flow cytometer before, during, and after exercise

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in CD63+ expression before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The CD63+ expression will be measured using flow cytometry before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in % of classical monocytes before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The % of classical monocytes will be measured using flow cytometry before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in % of intermediate monocytes before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The % of intermediate monocytes will be measured using flow cytometry before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in % of non-classical monocytes before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The % of non-classical monocytes will be measured using flow cytometry before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in TLR-4 expression on classical monocytes before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The TLR-4 expression on classical monocytes will be measured using flow cytometry before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in TLR-4 expression on intermediate monocytes before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The TLR-4 expression on intermediate monocytes will be measured using flow cytometry before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in TLR-4 expression on non-classical monocytes before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The TLR-4 expression on non-classical monocytes will be measured using flow cytometry before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in plasma IL-6 before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The plasma IL-6 concentration will be measured using a multiplex assay before, during, and after exercise

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in plasma IL-10 before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The plasma IL-10 concentration will be measured using a multiplex assay before, during, and after exercise.

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in plasma TNF-α before, during, and after exercise
기간: Pre-exercise, during 32 minute of exercise, immediately post-exercise

The plasma TNF-α concentration will be measured using a multiplex assay before, during, and after exercise

Pre-exercise, during 32 minute of exercise, immediately post-exercise
Change in 4-h LPS-induced TNF-α before and after exercise
기간: Pre-exercise, immediately post-exercise

The LPS-induced TNF-α concentration will be measured from whole-blood culture supernatant using an ELISA before and after exercise.

Pre-exercise, immediately post-exercise
Change in 4-h LPS+IL10-induced TNF-α before and after exercise
기간: Pre-exercise, immediately post-exercise

The LPS+IL10-induced TNF-α concentration will be measured from whole-blood culture supernatant using an ELISA before and after exercise.

Pre-exercise, immediately post-exercise

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2026년 2월 11일

기본 완료 (추정된)

2027년 12월 31일

연구 완료 (추정된)

2027년 12월 31일

연구 등록 날짜

최초 제출

2026년 6월 23일

QC 기준을 충족하는 최초 제출

2026년 11월 3일

처음 게시됨 (실제)

2026년 11월 10일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 11월 10일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 11월 3일

마지막으로 확인됨

2026년 11월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다